EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential

Hossein Omidian iD, Renae L Wilson

Pharmaceuticals · 27.04.2025 · 18 (5) · 631

DOI: 10.3390/ph18050631 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 27.04.2025. Verfasst von Hossein Omidian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly(lactide-co-glycolide) (PLGA) implants have become a cornerstone in drug delivery and regenerative medicine due to their biocompatibility, tunable degradation, and capacity for sustained, localized therapeutic release. Recent innovations in polymer design, fabrication methods, and functional modifications have expanded their utility across diverse clinical domains, including oncology, neurology, orthopedics, and ophthalmology. This review provides a comprehensive analysis of PLGA implant properties, fabrication strategies, and biomedical applications, while addressing key challenges such as burst release, incomplete drug release, manufacturing complexity, and inflammatory responses. Emerging solutions—such as 3D printing, in situ forming systems, predictive modeling, and patient-specific customization—are improving implant performance and clinical translation. Emphasis is placed on scalable production, long-term biocompatibility, and personalized design to support the next generation of precision therapeutics.

Schlagwörter

Stichwörter der Autor:innen

3D printingPLGA implantsbiocompatible polymerscontrolled drug deliveryin situ forming systemspersonalized implantspredictive modelingregenerative medicine

Autor:innen und Institutionen

  • Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.

ORCID-Profile: Hossein Omidian

Zitieren

APA

Omidian, H., & Wilson, R. L. (2025). PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential. Pharmaceuticals, 18(5), 631. https://doi.org/10.3390/ph18050631

Vancouver

Omidian H, Wilson RL. PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential. Pharmaceuticals. 2025;18(5):631. doi:10.3390/ph18050631

BibTeX
@article{Omidian2025,
  author = {Omidian, Hossein and Wilson, Renae L},
  title = {PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {5},
  pages = {631},
  doi = {10.3390/ph18050631}
}
Kostenlos starten →